World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
45472
World Ranking
7278
National Ranking
709

Overview

Michael G. Hanna is affiliated with University College London in the United Kingdom. Their research spans multiple fields of study, primarily within medicine and biochemistry, genetics, and molecular biology.

Their work covers a number of subfields including molecular biology, genetics, cellular and molecular neuroscience, cardiology and cardiovascular medicine, and neurology. These areas reflect a diverse focus on both fundamental biological processes and clinical applications.

Main topics of research addressed by Michael G. Hanna include:

  • Genetic Neurodegenerative Diseases
  • Mitochondrial Function and Pathology
  • Ion channel regulation and function
  • Muscle Physiology and Disorders
  • Metabolism and Genetic Disorders
  • Genomics and Rare Diseases
  • Inflammatory Myopathies and Dermatomyositis

They have contributed numerous publications within several key academic journals. Frequent publication venues are:

  • Neuromuscular Disorders
  • Muscle & Nerve
  • Brain
  • Journal of Neurology Neurosurgery & Psychiatry
  • bioRxiv (Cold Spring Harbor Laboratory)

Michael G. Hanna collaborates regularly with a group of coauthors, among whom the most frequent are:

  • Robert D. S. Pitceathly
  • Henry Houlden
  • Emma Matthews
  • Enrico Bugiardini
  • Pedro Machado

Some of their recent papers demonstrate the range of their research interests and contributions. These include:

  • Cardiolipin, Mitochondria, and Neurological Disease (2021), published in Trends in Endocrinology and Metabolism
  • British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (2022), published in Lara D. Veeken
  • Guidelines on clinical presentation and management of nondystrophic myotonias (2020), published in Muscle & Nerve
  • Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study (2021), published in BMJ
  • Solving patients with rare diseases through programmatic reanalysis of genome-phenome data (2021), published in European Journal of Human Genetics

Best Publications

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.

    Stefan H. Hohnloser;Ziad Hijazi;Laine Thomas;John H. Alexander

  • Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

    Jan B Vermorken;Anke M E Claessen;Harm van Tinteren;Helen E Gall

  • Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Renato D. Lopes;John H. Alexander;Sana M. Al-Khatib;Jack Ansell

  • Exercise Intolerance Due to Mutations in the Cytochrome b Gene of Mitochondrial DNA

    Antoni L. Andreu;Michael G. Hanna;Heinz Reichmann;Claudio Bruno

  • Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel

    Anne Jouvenceau;Anne Jouvenceau;Louise H Eunson;Alexander Spauschus;Alexander Spauschus;Venkataswaran Ramesh

  • Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene

    R Horvath;G Hudson;G Ferrari;N Futterer

  • Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

    Sigrun Halvorsen;Dan Atar;Dan Atar;Hongqiu Yang;Raffaele De Caterina

  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Ziad Hijazi;Johan Lindbäck;John H. Alexander;Michael Hanna

  • A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.

    S. M. Zuberi;L. H. Eunson;A. Spauschus;R. De Silva

  • The primary periodic paralyses: diagnosis, pathogenesis and treatment

    S. L. Venance;S. C. Cannon;D. Fialho;B. Fontaine

  • Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes

    Elaine M. Hylek;Claes Held;John H. Alexander;Renato D. Lopes

  • Primary episodic ataxias: diagnosis, pathogenesis and treatment.

    J.C. Jen;T.D. Graves;E.J. Hess;M.G. Hanna

  • Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

    J Donald Easton;Renato D Lopes;M Cecilia Bahit;Daniel M Wojdyla

  • Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    Lars Wallentin;Ziad Hijazi;Ulrika Andersson;John H. Alexander

  • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

    D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein

  • MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

    Jasper M Morrow;Christopher D J Sinclair;Arne Fischmann;Arne Fischmann;Pedro M Machado

  • Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability

    L. H. Eunson;R. Rea;S. M. Zuberi;S. Youroukos

  • Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions

    Hsien Yang Lee;Yong Huang;Yong Huang;Nadine Bruneau;Patrice Roll

  • Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary

    Salvatore Dimauro;Guido Davidzon;Michio Hirano;Rita Horvath

Frequent Co-Authors

Mary M. Reilly
Mary M. Reilly University College London
Renato D. Lopes
Renato D. Lopes Duke University
John H. Alexander
John H. Alexander Duke University
Christopher B. Granger
Christopher B. Granger Duke University
Lars Wallentin
Lars Wallentin Uppsala University
Dimitri M. Kullmann
Dimitri M. Kullmann University College London
Francesco Muntoni
Francesco Muntoni University College London
Janice L. Holton
Janice L. Holton University College London
Henry Houlden
Henry Houlden University College London
Tarek A. Yousry
Tarek A. Yousry University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to a variety of rewarding healthcare careers beyond traditional medical school. Many students consider nursing, and for some, finding what is the easiest nursing school to get into can be a practical route into the profession. Some nursing programs even offer admission without entrance tests, so researching nursing school no entrance exam options may accelerate your journey.

Not all healthcare careers require direct patient care. Administrative and technical fields, such as medical billing, coding, and healthcare management, are also in high demand. For those seeking convenient and affordable study, consider medical billing and coding online schools that accept financial aid. Pursuing a recognized management credential can further broaden your options; many choose a healthcare administration degree online accredited for flexibility and career advancement.

With diverse online pathways and accessible programs, you can start your healthcare journey in the way that works best for you. Thorough research ensures you find accredited programs, financial support, and a pathway that aligns with your goals.

Best Scientists Citing Michael G. Hanna

Trending Scientists